The effect of CBDEX 10 in type 2 diabetes
Phase 3
Recruiting
- Conditions
- Diabet.Type 2 diabetes mellitus without complicationsE11.9
- Registration Number
- IRCT20121021011192N10
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
En Type 2 diabetes based on ADA (American Diabetes Association) guideline
Age older than 18 years old
Exclusion Criteria
Uncontrolled seizure & untreated major depressive disorder
Pregnancy & lactation
eGFR less than 30 ml/min/1.73m2
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hemoglobin A1c (HbA1c) values. Timepoint: Before intervention and 60 days after initiation of daily use of spray. Method of measurement: Lab kits.
- Secondary Outcome Measures
Name Time Method Record of Adverse drug reactions. Timepoint: During intervention. Method of measurement: Interview with patients.